0001209191-15-010571.txt : 20150206
0001209191-15-010571.hdr.sgml : 20150206
20150206212753
ACCESSION NUMBER: 0001209191-15-010571
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150204
FILED AS OF DATE: 20150206
DATE AS OF CHANGE: 20150206
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Paratek Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001178711
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 330960223
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 75 KNEELAND STREET
STREET 2: 6TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02111
BUSINESS PHONE: (617) 275-0040
MAIL ADDRESS:
STREET 1: 75 KNEELAND STREET
STREET 2: 6TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02111
FORMER COMPANY:
FORMER CONFORMED NAME: Transcept Pharmaceuticals Inc
DATE OF NAME CHANGE: 20090130
FORMER COMPANY:
FORMER CONFORMED NAME: NOVACEA INC
DATE OF NAME CHANGE: 20020724
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Stein Jeffrey
CENTRAL INDEX KEY: 0001478831
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36066
FILM NUMBER: 15586539
MAIL ADDRESS:
STREET 1: 6310 NANCY RIDGE DRIVE, SUITE 101
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2015-02-04
0
0001178711
Paratek Pharmaceuticals, Inc.
PRTK
0001478831
Stein Jeffrey
C/O PARATEK PHARMACEUTICALS, INC.
75 KNEELAND STREET
BOSTON
MA
02111
1
0
0
0
Stock Option (right to buy)
24.07
2015-02-04
4
A
0
20000
0.00
A
2025-02-03
Common Stock
20000
20000
D
The exercise price is equal to the closing sales price per share of Common Stock as reported on The Nasdaq Global Market on the date of grant.
1/36th of the shares vest on a monthly basis.
/s/ Michael Bigham, Attorney-in-Fact for Jeffrey Stein
2015-02-06